M&A deals announced worldwide in July included a rail merger, which is the largest transaction in the past 12 months based on ...

MRK trims its 2025 sales range but lifts the lower end of its EPS outlook. Keytruda, Animal Health and new drugs are expected ...

LGND READ THE FULL LGND RESEARCH REPORT Ligand Pharmaceuticals, Inc. (NASDAQ:LGND) reported second quarter 2025 financial and ...

Merck MRK stock has declined 4% since it announced second-quarter results on July 29 before market open. While the company’s ...

Get insights from Ligand Pharmaceuticals' Q2 2025 earnings—57% royalty revenue growth, raised guidance, and key partnerships driving long-term growth.

Merck pulled off its $10 billion buyout of Verona Pharma last month with little of the wheeling and dealing that typically ...

Investing in index funds is a safe way to grow your portfolio over the years. But there's a huge advantage to picking ...

The bumpy brick road of Verona Boulevard is no more after the completion of a joint paving project between the city of Pittsburgh and the Lincoln Park neighborhood of Penn Hills. Pittsburgh City ...

Verona Pharma plc (NASDAQ:VRNA) is one of the best multibagger stocks according to hedge funds. On July 9, 2025, Merck & Co. unveiled a $10 billion agreement to acquire Verona Pharma at $107 per ...

SOUTH EUCLID, Ohio — Two men were arraigned Monday in South Euclid Municipal Court on charges of aggravated murder following the fatal shooting of 18-year-old Jerimiah Hawkins. Marlon Nesbitt ...